FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, have announced the addition of the Life Whisperer Genetics module to its Life Whisperer software package (launched in 2021), enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilisation (IVF). Life Whisperer Genetics used in conjunction with Life Whisperer Viability uniquely aids in the clinical selection of blastocysts that may have a greater likelihood of being euploid and resulting in pregnancy using a single platform.
“At Presagen, we continue with our goal to improving health through the implementation of Life Whisperer Genetics artificial intelligence,” said Dr. Michelle Perugini, Chief Executive Officer and Co-Founder at Presagen. “The Life Whisperer platform was developed with a network of IVF clinics around the world to provide a single suite of AI-based technologies for a non-invasive, objective option along with a seamless workflow solution to aid clinicians in the IVF process.”
The Life Whisperer platform’s artificial intelligence (AI)-based approach analyses day 5 blastocysts’ morphological features that correlate with increased likelihood of clinical pregnancy to produce a confidence score from 0 to 10 across both Life Whisperer Viability and Life Whisperer Genetics modules. Research has shown Life Whisperer Viability may improve selection of viable embryos by up to 25% vs. embryologist assessment alone. In a simulated cohort study, Life Whisperer Genetics identified the top-ranked embryo as euploid in 82.4% of cohorts. By using the non-invasive single platform, the embryologist or clinician has an objective assessment and consistent grading aid to clinical decision-making and helping patients build families.
Steven Geimer, Executive Director of Medical Business Unit at FUJIFILM Irvine Scientific, said: “The Life Whisperer platform further solidifies our commitment to introduce new solutions to support embryologists and clinicians in increasing a patient’s pregnancy potential. AI-based analysis is one example of how we continue to push for innovative, non-invasive solutions to provide clinicians with objective decision-making tools in IVF procedures and clinic workflows, thereby assisting in achieving the desired results.”